Vision for Biomanufacturing: Today’s Challenges and Tomorrow’s Therapies
Joseph C. Famulare
Biopharmaceutical manufacturing faces many new opportunities as we enter this decade. ISPE is returning to Boston for the 2020 ISPE Biopharmaceutical Manufacturing Conference on 1-3 June 2020, bringing you once again an innovative conference, followed by the 2020 ISPE Continuous Manufacturing Workshop and relevant training classes 4-5 June 2020. The Boston area, including Cambridge, is home to over 1,000 biotechnology companies, leading research, and academic institutions advancing biotechnology medicines.
This year, the 2020 ISPE Biopharmaceutical Manufacturing Conference will focus on advances in manufacturing, facilities, and analytics important to bring new therapies to patients. Now more than ever, manufacturing is on the critical path as many new treatments in the area of personalized medicines and individualized batch production present the challenge to bring these medicines through rapid development, reliable manufacturing, and availability to patients a pace with the advances clinical research is bringing to address unmet needs. At the same time, biosimilars are advancing with the opportunity to provide more access to medicines.
Topics that will be addressed at this conference include:
Production of monoclonal antibodies
Sterile fill finish operations and testing
Large volume and small batch production
Single use technology
Construction and operation
Cell and gene therapy manufacturing and supply chain logistics
Evolution in analytical testing
Design and set up of laboratory operations
Session leaders and speakers are top leaders and experts in their fields of industry, regulatory, and/or academia. Topics will cover how we continually improve and manufacture our current processes, and continue to advance into new modalities. At the same time, the sessions will address how conventional norms of manufacturing testing and regulatory GMP and CMC oversight are advancing to meet patient needs.
Keep watching as our agenda advances, with updates from our planning committee. I look forward to seeing you in Boston in June.
If you work in the parenteral manufacturing space, it’s a foregone conclusion that you can pinpoint the emotion and anxiety that comes from receiving word that the FDA has arrived at your facility for an inspection. If Billy Joel were to pen the lyrics...
The theme of “Proactive Career Design” for the Women in Pharma® (WIP) Breakfast Session at the 2020 ISPE Facilities of the Future conference on 31 January in San Francisco was a fitting one: design and implementation apply equally well to careers as to...
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from January 2020. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last...